Delivery Order SPE2DB20D3101-SPE2DB22FH2D7
Award Date 12/2/21
Potential Completion Date 12/3/21
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,770.07, is for the supply of Carafate 1 gram/10 milliliter suspension in 420 milliliter containers. The contract is a firm-fixed-price delivery order, with a completion date of May 14, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
- This federal contract award, with ID SPE2DB20D1100|SPE2DB24FZ19P, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,103.83 firm-fixed-price delivery order contract is for the supply of Carafate 1 GM/10 ML Suspension, a pharmaceutical product. The contract has no set-aside designation, indicating open competition. It is associated with a larger Indefinite Delivery Contract (IDC) valued at up to...
- This federal contract award is a delivery order (SPE2DB22FF6Q9) valued at $9,706.25, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the supply of CARAFATE 1 GM/10 ML SUSP 420ML, a medication used to treat certain stomach and esophagus problems. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Carafate 1 GM Tablets, a medication used to treat certain stomach and duodenal ulcers. The contract has a ceiling value of $24,143.88 and a completion date of December 14, 2023. This contract is not designated as a set-aside. AmerisourceBergen holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,963.38 delivery order is for the supply of Sucralfate 1 GM/10 ML Suspension, a medication used to treat stomach and intestinal ulcers. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 and running through...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and subsidiary of Cencora, Inc. The $1,239.18 firm fixed-price delivery order is for the supply of 4,560,242,783 units of Sucralfate 1 GM/10 ML Suspension in 420 ML containers. The contract has an ultimate completion date of March 14, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award to Amerisourcebergen Drug Corp (CAGE Code KABZK8W6PQT3) was issued by the Defense Logistics Agency (DLA) on May 21, 2024. The $3,678.86 firm fixed-price delivery order (SPE2DB24FHH60) is for the supply of CARAFATE 1 GM/10 ML SUSP 420ML, a pharmaceutical product. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,604.04, is a delivery order for the supply of Sucralfate 1 GM/10 ML Suspension for a period ending on December 31, 2024. The contract is a firm fixed-price agreement and is not designated as a set-aside. Amerisourcebergen Drug Corp is the prime contractor, and the contract does not reference...
- This federal contract award, valued at $1,728.31, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Sucralfate 1 GM/10 ML Suspension in 420 ML quantities. No set-aside designation was used for this award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award, with ID SPE2DB20D1100|SPE2DB24FZ52T, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,688.20 firm fixed-price delivery order is for the supply of 4,563,214,896 units of Sucralfate 1 GM/10 ML Suspension, with a completion date of January 3, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...